vs
STANDARD BIOTOOLS INC.（LAB）与NATIONAL BANKSHARES INC（NKSH）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是NATIONAL BANKSHARES INC的1.3倍（$19.6M vs $15.3M），NATIONAL BANKSHARES INC净利率更高（38.5% vs -177.4%，领先215.9%），NATIONAL BANKSHARES INC同比增速更快（24.7% vs -11.5%），NATIONAL BANKSHARES INC自由现金流更多（$15.2M vs $-23.1M），过去两年NATIONAL BANKSHARES INC的营收复合增速更高（20.9% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
尼科特银行股份是一家美国区域性银行控股公司，总部位于威斯康星州格林贝，是尼科特国民银行的母公司，目前是威斯康星州规模第二大的本土银行，深耕当地市场开展各类银行相关金融业务。
LAB vs NKSH — 直观对比
营收规模更大
LAB
是对方的1.3倍
$15.3M
营收增速更快
NKSH
高出36.2%
-11.5%
净利率更高
NKSH
高出215.9%
-177.4%
自由现金流更多
NKSH
多$38.2M
$-23.1M
两年增速更快
NKSH
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $15.3M |
| 净利润 | $-34.7M | $5.9M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 47.4% |
| 净利率 | -177.4% | 38.5% |
| 营收同比 | -11.5% | 24.7% |
| 净利润同比 | -28.8% | 91.0% |
| 每股收益（稀释后） | $-0.09 | $0.93 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABNKSH
| Q4 25 | — | $15.3M | ||
| Q3 25 | $19.6M | $14.2M | ||
| Q2 25 | $21.8M | $13.3M | ||
| Q1 25 | $40.8M | $12.8M | ||
| Q4 24 | — | $12.2M | ||
| Q3 24 | $22.1M | $11.7M | ||
| Q2 24 | $22.5M | $10.9M | ||
| Q1 24 | $45.5M | $10.4M |
净利润LABNKSH
| Q4 25 | — | $5.9M | ||
| Q3 25 | $-34.7M | $4.4M | ||
| Q2 25 | $-33.5M | $2.3M | ||
| Q1 25 | $-26.0M | $3.2M | ||
| Q4 24 | — | $3.1M | ||
| Q3 24 | $-26.9M | $2.7M | ||
| Q2 24 | $-45.7M | $-307.0K | ||
| Q1 24 | $-32.2M | $2.2M |
毛利率LABNKSH
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
营业利润率LABNKSH
| Q4 25 | — | 47.4% | ||
| Q3 25 | -168.5% | 37.9% | ||
| Q2 25 | -118.1% | 20.0% | ||
| Q1 25 | -80.8% | 30.5% | ||
| Q4 24 | — | 30.1% | ||
| Q3 24 | -120.9% | 27.5% | ||
| Q2 24 | -134.5% | -4.4% | ||
| Q1 24 | -132.2% | 25.8% |
净利率LABNKSH
| Q4 25 | — | 38.5% | ||
| Q3 25 | -177.4% | 31.1% | ||
| Q2 25 | -153.7% | 17.2% | ||
| Q1 25 | -63.8% | 25.3% | ||
| Q4 24 | — | 25.1% | ||
| Q3 24 | -122.0% | 22.8% | ||
| Q2 24 | -203.3% | -2.8% | ||
| Q1 24 | -70.6% | 20.8% |
每股收益（稀释后）LABNKSH
| Q4 25 | — | $0.93 | ||
| Q3 25 | $-0.09 | $0.69 | ||
| Q2 25 | $-0.09 | $0.36 | ||
| Q1 25 | $-0.07 | $0.51 | ||
| Q4 24 | — | $0.50 | ||
| Q3 24 | $-0.07 | $0.42 | ||
| Q2 24 | $-0.12 | $-0.05 | ||
| Q1 24 | $-0.27 | $0.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $59.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $184.9M |
| 总资产 | $539.6M | $1.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABNKSH
| Q4 25 | — | $59.3M | ||
| Q3 25 | $129.4M | $42.3M | ||
| Q2 25 | $158.6M | $92.8M | ||
| Q1 25 | $150.9M | $122.5M | ||
| Q4 24 | — | $108.1M | ||
| Q3 24 | $210.6M | $49.8M | ||
| Q2 24 | $269.8M | $98.9M | ||
| Q1 24 | $287.1M | $121.2M |
总债务LABNKSH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
股东权益LABNKSH
| Q4 25 | — | $184.9M | ||
| Q3 25 | $399.7M | $179.2M | ||
| Q2 25 | $424.5M | $168.7M | ||
| Q1 25 | $454.6M | $167.3M | ||
| Q4 24 | — | $156.4M | ||
| Q3 24 | $489.3M | $167.8M | ||
| Q2 24 | $510.3M | $149.0M | ||
| Q1 24 | $577.3M | $139.4M |
总资产LABNKSH
| Q4 25 | — | $1.8B | ||
| Q3 25 | $539.6M | $1.8B | ||
| Q2 25 | $557.0M | $1.8B | ||
| Q1 25 | $579.6M | $1.8B | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | $681.5M | $1.8B | ||
| Q2 24 | $708.7M | $1.8B | ||
| Q1 24 | $777.7M | $1.7B |
负债/权益比LABNKSH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $17.9M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $15.2M |
| 自由现金流率自由现金流/营收 | -118.1% | 99.2% |
| 资本支出强度资本支出/营收 | 4.5% | 17.9% |
| 现金转化率经营现金流/净利润 | — | 3.04× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $23.6M |
8季度趋势，按日历期对齐
经营现金流LABNKSH
| Q4 25 | — | $17.9M | ||
| Q3 25 | $-22.2M | $6.1M | ||
| Q2 25 | $-20.7M | $2.1M | ||
| Q1 25 | $-30.3M | $2.6M | ||
| Q4 24 | — | $9.4M | ||
| Q3 24 | $-27.9M | $3.1M | ||
| Q2 24 | $-39.0M | $-3.0M | ||
| Q1 24 | $-62.5M | $3.8M |
自由现金流LABNKSH
| Q4 25 | — | $15.2M | ||
| Q3 25 | $-23.1M | $5.3M | ||
| Q2 25 | $-22.6M | $1.5M | ||
| Q1 25 | $-35.3M | $1.6M | ||
| Q4 24 | — | $6.2M | ||
| Q3 24 | $-30.1M | $2.2M | ||
| Q2 24 | $-41.0M | $-4.0M | ||
| Q1 24 | $-63.3M | $3.5M |
自由现金流率LABNKSH
| Q4 25 | — | 99.2% | ||
| Q3 25 | -118.1% | 37.4% | ||
| Q2 25 | -103.6% | 11.5% | ||
| Q1 25 | -86.6% | 12.5% | ||
| Q4 24 | — | 50.5% | ||
| Q3 24 | -136.4% | 18.5% | ||
| Q2 24 | -182.2% | -36.3% | ||
| Q1 24 | -138.9% | 33.8% |
资本支出强度LABNKSH
| Q4 25 | — | 17.9% | ||
| Q3 25 | 4.5% | 5.6% | ||
| Q2 25 | 8.7% | 4.1% | ||
| Q1 25 | 12.4% | 7.5% | ||
| Q4 24 | — | 26.6% | ||
| Q3 24 | 10.2% | 8.3% | ||
| Q2 24 | 8.6% | 9.3% | ||
| Q1 24 | 1.7% | 3.0% |
现金转化率LABNKSH
| Q4 25 | — | 3.04× | ||
| Q3 25 | — | 1.38× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.79× | ||
| Q4 24 | — | 3.07× | ||
| Q3 24 | — | 1.17× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.77× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
NKSH
暂无分部数据
